News Release 

Probiotics with top-performing Lactobacillus strains may improve vaginal health

PLOS

IMAGE

IMAGE: Assessment characteristics in the hunt for novel vaginal probiotics for Africa view more 

Credit: Sean Crozier, 2020

Vaginal Lactobacillus bacterial strains largely perform better than strains currently used in probiotics for vaginal health, according to a study published June 4 in the open-access journal PLOS Pathogens by Jo-Ann Passmore of the University of Cape Town, and colleagues. The findings suggest that a vaginal health probiotic that includes top-performing vaginal Lactobacillus strains may improve treatment options for bacterial vaginosis.

Lactobacillus species in the lower reproductive tract of healthy women lower vaginal pH and protect against sexually transmitted infections. But women commonly suffer from bacterial vaginosis -- a disruption in the optimal Lactobacillus-dominated genital microbiota - resulting in higher vaginal pH as well as vaginal discharge and inflammation. Bacterial vaginosis is associated with adverse pregnancy outcomes and a higher risk of sexually transmitted infections, including HIV. Although antibiotics are the standard of care for bacterial vaginosis, most cases recur within six months. Probiotics that include Lactobacilli have been explored to improve the durability of treatment, but the majority of products do not contain species commonly found in the vagina. There is an urgent need for the development of additional well-designed probiotics for vaginal health.

In the new study, Passmore and colleagues compared 57 vaginal Lactobacillus strains from young African women to strains from commercial probiotic products for vaginal health. They analyzed their growth at varying pH values, ability to lower pH and produce antimicrobial products, pathogen inhibition, and susceptibility to antibiotics. Several vaginal strains exhibited better probiotic profiles than commercial strains, suggesting that they would be beneficial in the development of probiotic treatments for bacterial vaginosis. Moreover, whole-genome sequencing of the five best-performing vaginal strains revealed that they would likely be safe and not pose a risk of antimicrobial resistance. According to the authors, a wider range of well-characterized Lactobacillus-containing probiotics may improve treatment outcomes for bacterial vaginosis, and lower the risk of adverse pregnancy outcomes and sexually transmitted infections.

"Few probiotics aimed at promoting vaginal health contain Lactobacillus spp. that commonly colonize the lower genital tracts of African women," the authors add. "The discovery and use of novel vaginal probiotic strains in such women may improve the durability of bacterial vaginosis treatments and towards this end Happel et al. (2020) evaluated a multitude of vaginal Lactobacillus strains and identified some that should be tested as vaginal probiotics in clinical trials in Africa."

###

Research Article

Funding: JSP is supported by EDCTP Strategic Primer SP.2011.41304.038; Poliomyelitis Research Foundation Award 15/23; SA National Research Foundation (NRF) South Africa / France Science and Technology Research collaboration Protea grant FSTR180523333842. AUH is supported by University of Cape Town Post-graduate publication incentive funding; Poliomyelitis Research Foundation Award; SA National Research Foundation (NRF). NW is supported by South African Medical Research Council Division of Research Capacity Development under National Medical Students Research Training Programme. The authors confirm that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing Interests: The authors have declared that no competing interests exist.

Citation: Happel A-U, Kullin B, Gamieldien H, Wentzel N, Zauchenberger CZ, Jaspan HB, et al. (2020) Exploring potential of vaginal Lactobacillus isolates from South African women for enhancing treatment for bacterial vaginosis. PLoS Pathog 16(6): e1008559. https://doi.org/10.1371/journal.ppat.1008559

Author Affiliations:

National Health Laboratory Service (NHLS), Cape Town, South Africa
South African Medical Research Council, Cape Town, South Africa
University of Cape Town, Cape Town, South Africa
University Montpellier, Montpellier, France
University of the Witwatersrand, Johannesburg, South Africa

In your coverage please use this URL to provide access to the freely available paper: http://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1008559

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.